249 related articles for article (PubMed ID: 33707613)
1. Initial therapeutic dose of corticosteroid for an acute exacerbation of IPF is associated with subsequent early recurrence of another exacerbation.
Yamazaki R; Nishiyama O; Saeki S; Sano H; Iwanaga T; Tohda Y
Sci Rep; 2021 Mar; 11(1):5782. PubMed ID: 33707613
[TBL] [Abstract][Full Text] [Related]
2. Study protocol: exploring the efficacy of cyclophosphamide added to corticosteroids for treating acute exacerbation of idiopathic pulmonary fibrosis; a randomized double-blind, placebo-controlled, multi-center phase III trial (EXAFIP).
Naccache JM; Montil M; Cadranel J; Cachanado M; Cottin V; Crestani B; Valeyre D; Wallaert B; Simon T; Nunes H
BMC Pulm Med; 2019 Apr; 19(1):75. PubMed ID: 30971235
[TBL] [Abstract][Full Text] [Related]
3. Pulse versus non-pulse corticosteroid therapy in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Hyung K; Lee JH; Kim JY; Choi SM; Park J
Respirology; 2024 Mar; 29(3):235-242. PubMed ID: 38087838
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF.
Farrand E; Vittinghoff E; Ley B; Butte AJ; Collard HR
Respirology; 2020 Jun; 25(6):629-635. PubMed ID: 31846126
[TBL] [Abstract][Full Text] [Related]
5. Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study.
Furuya K; Sakamoto S; Shimizu H; Sekiya M; Kinoshita A; Isshiki T; Sugino K; Matsumoto K; Homma S
Respir Med; 2017 May; 126():93-99. PubMed ID: 28427556
[TBL] [Abstract][Full Text] [Related]
6. Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?
Cuerpo S; Moisés J; Hernández-González F; Benegas M; Ramirez J; Sánchez M; Agustí À; Sellares J
Chron Respir Dis; 2019; 16():1479973119869334. PubMed ID: 31431063
[TBL] [Abstract][Full Text] [Related]
7. Time for Prevention of Idiopathic Pulmonary Fibrosis Exacerbation.
Richeldi L
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S181-5. PubMed ID: 26595737
[TBL] [Abstract][Full Text] [Related]
8. Early corticosteroid dose tapering in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Anan K; Kataoka Y; Ichikado K; Kawamura K; Johkoh T; Fujimoto K; Tobino K; Tachikawa R; Ito H; Nakamura T; Kishaba T; Inomata M; Kamitani T; Yamazaki H; Ogawa Y; Yamamoto Y
Respir Res; 2022 Oct; 23(1):291. PubMed ID: 36289512
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department.
Jang HJ; Yong SH; Leem AY; Lee SH; Kim SY; Lee SH; Kim EY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
Sci Rep; 2021 Mar; 11(1):5762. PubMed ID: 33707643
[TBL] [Abstract][Full Text] [Related]
10. Acute exacerbation of chronic fibrosing interstitial pneumonia in patients receiving antifibrotic agents: incidence and risk factors from real-world experience.
Kawamura K; Ichikado K; Ichiyasu H; Anan K; Yasuda Y; Suga M; Sakagami T
BMC Pulm Med; 2019 Jun; 19(1):113. PubMed ID: 31238929
[TBL] [Abstract][Full Text] [Related]
11. Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.
Zantah M; Dotan Y; Dass C; Zhao H; Marchetti N; Criner GJ
Respir Res; 2020 Jun; 21(1):164. PubMed ID: 32605574
[TBL] [Abstract][Full Text] [Related]
12. Clinical course and prognosis in survivors of acute exacerbations of idiopathic pulmonary fibrosis.
Yamazaki R; Nishiyama O; Yoshikawa K; Saeki S; Sano H; Iwanaga T; Tohda Y
Respir Investig; 2021 Jul; 59(4):408-413. PubMed ID: 33549542
[TBL] [Abstract][Full Text] [Related]
13. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
Ryerson CJ; Cottin V; Brown KK; Collard HR
Eur Respir J; 2015 Aug; 46(2):512-20. PubMed ID: 26232481
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Hozumi H; Hasegawa H; Miyashita K; Yasui H; Suzuki Y; Kono M; Karayama M; Furuhashi K; Hashimoto D; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Respirology; 2019 Aug; 24(8):792-798. PubMed ID: 30803100
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).
Iwata T; Yoshino I; Yoshida S; Ikeda N; Tsuboi M; Asato Y; Katakami N; Sakamoto K; Yamashita Y; Okami J; Mitsudomi T; Yamashita M; Yokouchi H; Okubo K; Okada M; Takenoyama M; Chida M; Tomii K; Matsuura M; Azuma A; Iwasawa T; Kuwano K; Sakai S; Hiroshima K; Fukuoka J; Yoshimura K; Tada H; Nakagawa K; Nakanishi Y;
Respir Res; 2016 Jul; 17(1):90. PubMed ID: 27450274
[TBL] [Abstract][Full Text] [Related]
16. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
Tsushima K; Yamaguchi K; Kono Y; Yokoyama T; Kubo K; Matsumura T; Ichimura Y; Abe M; Terada J; Tatsumi K
Pulm Pharmacol Ther; 2014 Dec; 29(2):233-40. PubMed ID: 24836398
[TBL] [Abstract][Full Text] [Related]
17. Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report.
Hirai K; Homma T; Yamaguchi F; Yamaguchi M; Suzuki S; Tanaka A; Ohnishi T; Sagara H
BMC Pulm Med; 2019 Jan; 19(1):15. PubMed ID: 30642317
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of macrolide treatment in idiopathic pulmonary fibrosis: a retrospective analysis.
Kuse N; Abe S; Hayashi H; Kamio K; Saito Y; Usuki J; Azuma A; Kudoh S; Gemma A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):242-246. PubMed ID: 27758989
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment of acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study of 88 patients.
Sakamoto S; Shimizu H; Isshiki T; Kurosaki A; Homma S
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(3):176-184. PubMed ID: 32476952
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
